ASCO

@ASCO · Alexandria, VA · joined 05 Feb 2009

Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.

151 697Followers

2 403Following

41 940Posts total

38.5KViews on collected posts

Against accounts of the same size

4 posts from the last 90 days, next to the 100K–1M follower range. below its peers on both reach and engagement.

Median views2 036this account12 273median for 100K–1M

Reach, %1.34%this account3.89%median for 100K–1M

Engagement, %0.42%this account1.25%median for 100K–1M

Metric	This account	Median for 100K–1M	Ratio
Median views per post	2 036	12 273	0.17×
Reach (views ÷ followers)	1.34%	3.89%	0.35×
Engagement rate	0.42%	1.25%	0.33×

Others in this range → Compare with another account → How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

28.4K2 Jun

4.9K1 Sep

2.8K2 Sep

1.3K3 Sep

1.2K

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.89%2 Jun

0.33%1 Sep

0.51%2 Sep

0.00%3 Sep

0.69%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 1.25%.

What the audience does

Likes55.9%165 in total

Reposts16.6%49 in total

Replies22.0%65 in total

Quotes4.1%12 in total

Bookmarks1.4%4 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Latest posts

Thank you ASCO member Dr. @fumikochino for speaking on the importance of federal cancer research funding! #ASCOAdvocacy continues to urge Congress to pass a full, bipartisan FY27 bill to provide the strongest possible investments in medical research. https://t.co/7sGoh7b6CA 1.2K views · 7 likes · 1 reposts · 0 replies 03 Sep 2026 ⏳ Last call! Early-career oncologists: secure your research funding and advance your career before it's too late. 📢 Apply for a mentored @ConquerCancerFd YIA or GO YIA by Sept. 10. Don't miss out—submit today: https://t.co/ayEcHZOkhr #ResearchConquersCancer https://t.co/e0Wut1 1.3K views · 0 likes · 0 reposts · 0 replies 03 Sep 2026 ⌚ Time is running out to level up your #MedEd game! We’re looking for the next wave of ed innovators to join the 2027-28 LDP: Education Scholars program. If you’re ready to master learning science & lead the charge, apply by Sept. 14: https://t.co/odDRnvyZMz https://t.co/Ay 2.8K views · 9 likes · 2 reposts · 2 replies 02 Sep 2026 #ASCOAdvocacy thanks the House for passing the CR to keep the government funded and delay the proposed federal grantmaking rule in the CR. More. https://t.co/C3HXTBgr29 4.9K views · 12 likes · 2 reposts · 2 replies 01 Sep 2026 #ASCO26 truly embodied the theme of translating science into global patient outcomes. We are grateful to the ~46,000 attendees, all working tirelessly to conquer cancer together! A heartfelt thanks to all. 💗 We can’t wait to see you next year at #ASCO27! https://t.co/eORRLMMJ3T 28.4K views · 137 likes · 44 reposts · 61 replies 02 Jun 2026